Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Apr 2024
When daicopan was combined with a C5 inhibitor, hemoglobin at 12 weeks was significantly improved.
Read Full News1.
Dostarlimab Boosts Long-Term Survival in Endometrial Cancer
2.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
3.
FDA Approves CAR-T Product Use for Myeloma Early.
4.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
5.
For incarcerated people, study shows gaps exist in quality of cancer care
1.
Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction
2.
Engineered Red Blood Cell Therapeutics: Emerging Applications
3.
Virtual Oncology Follow-Up: Current Practices, Evidence, and Clinical Implications
4.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
5.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
2.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
3.
Understanding the Role of Multidisciplinary Cancer Care
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge